BC

Boxer Capital Portfolio holdings

AUM $2.04B
1-Year Return 108.35%
This Quarter Return
+24.41%
1 Year Return
+108.35%
3 Year Return
+260.95%
5 Year Return
+1,103.68%
10 Year Return
–
AUM
$2.16B
AUM Growth
+$121M
Cap. Flow
+$773K
Cap. Flow %
0.04%
Top 10 Hldgs %
45.97%
Holding
84
New
9
Increased
5
Reduced
5
Closed
5

Top Buys

1
IMGN
Immunogen Inc
IMGN
$55.9M
2
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
$54.2M
3
LEGN icon
Legend Biotech
LEGN
$41.4M
4
AKRO icon
Akero Therapeutics
AKRO
$39.5M
5
ARGX icon
argenx
ARGX
$29.2M

Top Sells

1
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
$204M
2
SGEN
Seagen Inc. Common Stock
SGEN
$40.5M
3
BLU
BELLUS Health Inc.
BLU
$23M
4
SRPT icon
Sarepta Therapeutics
SRPT
$20M
5
MORF
Morphic Holding, Inc. Common Stock
MORF
$7.53M

Sector Composition

1 Healthcare 100%
2 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
AXSM icon
26
Axsome Therapeutics
AXSM
$6.25B
$28.7M 1.33%
400,000
– –
ITOS
27
DELISTED
iTeos Therapeutics
ITOS
$28.5M 1.32%
2,154,058
– –
VTYX icon
28
Ventyx Biosciences
VTYX
$180M
$27.9M 1.29%
850,000
– –
ANAB icon
29
AnaptysBio
ANAB
$613M
$26.4M 1.23%
1,300,000
– –
IOVA icon
30
Iovance Biotherapeutics
IOVA
$901M
$26.1M 1.21%
3,705,133
– –
TNGX icon
31
Tango Therapeutics
TNGX
$772M
$23.7M 1.1%
7,123,642
– –
MDGL icon
32
Madrigal Pharmaceuticals
MDGL
$9.65B
$23.1M 1.07%
+100,000
New +$23.1M
XENE icon
33
Xenon Pharmaceuticals
XENE
$3.02B
$23.1M 1.07%
600,000
– –
RLAY icon
34
Relay Therapeutics
RLAY
$710M
$22.8M 1.06%
1,819,132
-350,000
-16% -$4.4M
PNT
35
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
$22.7M 1.05%
2,500,000
– –
EXEL icon
36
Exelixis
EXEL
$10.2B
$22M 1.02%
1,150,000
– –
PRTA icon
37
Prothena Corp
PRTA
$460M
$20.5M 0.95%
300,000
– –
PMVP icon
38
PMV Pharmaceuticals
PMVP
$77.4M
$19.8M 0.92%
3,163,795
– –
KALV icon
39
KalVista Pharmaceuticals
KALV
$796M
$14.9M 0.69%
1,650,000
– –
ELVN icon
40
Enliven Therapeutics
ELVN
$1.19B
$14.5M 0.67%
710,644
– –
DAWN icon
41
Day One Biopharmaceuticals
DAWN
$773M
$14.2M 0.66%
1,189,943
– –
ORIC icon
42
Oric Pharmaceuticals
ORIC
$1.06B
$13.4M 0.62%
1,732,571
+678,571
+64% +$5.27M
ZNTL icon
43
Zentalis Pharmaceuticals
ZNTL
$126M
$12.7M 0.59%
+450,000
New +$12.7M
RNA icon
44
Avidity Biosciences
RNA
$6.48B
$12.4M 0.58%
1,121,327
– –
NRIX icon
45
Nurix Therapeutics
NRIX
$758M
$12.2M 0.57%
1,224,892
– –
CGEM icon
46
Cullinan Oncology
CGEM
$413M
$11.6M 0.54%
1,074,082
– –
PRLD icon
47
Prelude Therapeutics
PRLD
$69.6M
$11.2M 0.52%
2,495,018
+1,795,971
+257% +$8.08M
BDTX icon
48
Black Diamond Therapeutics
BDTX
$167M
$10.2M 0.47%
2,014,858
– –
GERN icon
49
Geron
GERN
$893M
$9.63M 0.45%
+3,000,000
New +$9.63M
ASND icon
50
Ascendis Pharma
ASND
$12.5B
$8.48M 0.39%
95,000
– –
1
2
3 4